Report Detail

Pharma & Healthcare Global (United States, European Union and China) Anti-inflammatory Therapeutics Market Research Report 2019-2025

  • RnM3665765
  • |
  • 13 August, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Anti-inflammatory therapeutics are primarily used to reduce inflammation. These drugs are types of analgesics that are used for reducing pain.
The global anti-inflammatory therapeutics market will grow steadily at a CAGR of over 6% by 2021. This market research analysis identifies the increase in the prevalence of immune-mediated inflammatory disease (IMID) as one of the primary growth factors for this market. IMID includes a group of disabling conditions that share a common inflammatory pathway including conditions like ankylosing spondylitis (AS), ulcerative colitis, multiple sclerosis (MS), rheumatoid arthritis (RA), and inflammatory bowel disease (IBD) and these conditions can affect an organ, resulting in significant morbidity and reduced quality of life.
In 2019, the market size of Anti-inflammatory Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-inflammatory Therapeutics.

This report studies the global market size of Anti-inflammatory Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-inflammatory Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AbbVie
Amgen
Johnson & Johnson
Pfizer
Boehringer Ingelheim
Eli Lilly
Novartis
...

Market Segment by Product Type
Anti-Inflammatory Biologicals
NSAIDs
Corticosteroids

Market Segment by Application
Hospitals
Clinics

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Anti-inflammatory Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-inflammatory Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Anti-inflammatory Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Anti-Inflammatory Biologicals
      • 1.3.3 NSAIDs
      • 1.3.4 Corticosteroids
    • 1.4 Market Segment by Application
      • 1.4.1 Global Anti-inflammatory Therapeutics Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Anti-inflammatory Therapeutics Market Size
      • 2.1.1 Global Anti-inflammatory Therapeutics Revenue 2014-2025
      • 2.1.2 Global Anti-inflammatory Therapeutics Sales 2014-2025
    • 2.2 Anti-inflammatory Therapeutics Growth Rate by Regions
      • 2.2.1 Global Anti-inflammatory Therapeutics Sales by Regions 2014-2019
      • 2.2.2 Global Anti-inflammatory Therapeutics Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Anti-inflammatory Therapeutics Sales by Manufacturers
      • 3.1.1 Anti-inflammatory Therapeutics Sales by Manufacturers 2014-2019
      • 3.1.2 Anti-inflammatory Therapeutics Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Anti-inflammatory Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Anti-inflammatory Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Anti-inflammatory Therapeutics Price by Manufacturers
    • 3.4 Key Manufacturers Anti-inflammatory Therapeutics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Anti-inflammatory Therapeutics Market
    • 3.6 Key Manufacturers Anti-inflammatory Therapeutics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Anti-Inflammatory Biologicals Sales and Revenue (2014-2019)
      • 4.1.2 NSAIDs Sales and Revenue (2014-2019)
      • 4.1.3 Corticosteroids Sales and Revenue (2014-2019)
    • 4.2 Global Anti-inflammatory Therapeutics Sales Market Share by Type
    • 4.3 Global Anti-inflammatory Therapeutics Revenue Market Share by Type
    • 4.4 Anti-inflammatory Therapeutics Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Anti-inflammatory Therapeutics Sales by Application

    6 United States

    • 6.1 United States Anti-inflammatory Therapeutics Breakdown Data by Company
    • 6.2 United States Anti-inflammatory Therapeutics Breakdown Data by Type
    • 6.3 United States Anti-inflammatory Therapeutics Breakdown Data by Application

    7 European Union

    • 7.1 European Union Anti-inflammatory Therapeutics Breakdown Data by Company
    • 7.2 European Union Anti-inflammatory Therapeutics Breakdown Data by Type
    • 7.3 European Union Anti-inflammatory Therapeutics Breakdown Data by Application

    8 China

    • 8.1 China Anti-inflammatory Therapeutics Breakdown Data by Company
    • 8.2 China Anti-inflammatory Therapeutics Breakdown Data by Type
    • 8.3 China Anti-inflammatory Therapeutics Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Anti-inflammatory Therapeutics Breakdown Data by Company
    • 9.2 Rest of World Anti-inflammatory Therapeutics Breakdown Data by Type
    • 9.3 Rest of World Anti-inflammatory Therapeutics Breakdown Data by Application
    • 9.4 Rest of World Anti-inflammatory Therapeutics Breakdown Data by Countries
      • 9.4.1 Rest of World Anti-inflammatory Therapeutics Sales by Countries
      • 9.4.2 Rest of World Anti-inflammatory Therapeutics Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 AbbVie
      • 10.1.1 AbbVie Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Anti-inflammatory Therapeutics
      • 10.1.4 Anti-inflammatory Therapeutics Product Introduction
      • 10.1.5 AbbVie Recent Development
    • 10.2 Amgen
      • 10.2.1 Amgen Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Anti-inflammatory Therapeutics
      • 10.2.4 Anti-inflammatory Therapeutics Product Introduction
      • 10.2.5 Amgen Recent Development
    • 10.3 Johnson & Johnson
      • 10.3.1 Johnson & Johnson Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Anti-inflammatory Therapeutics
      • 10.3.4 Anti-inflammatory Therapeutics Product Introduction
      • 10.3.5 Johnson & Johnson Recent Development
    • 10.4 Pfizer
      • 10.4.1 Pfizer Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Anti-inflammatory Therapeutics
      • 10.4.4 Anti-inflammatory Therapeutics Product Introduction
      • 10.4.5 Pfizer Recent Development
    • 10.5 Boehringer Ingelheim
      • 10.5.1 Boehringer Ingelheim Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Anti-inflammatory Therapeutics
      • 10.5.4 Anti-inflammatory Therapeutics Product Introduction
      • 10.5.5 Boehringer Ingelheim Recent Development
    • 10.6 Eli Lilly
      • 10.6.1 Eli Lilly Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Anti-inflammatory Therapeutics
      • 10.6.4 Anti-inflammatory Therapeutics Product Introduction
      • 10.6.5 Eli Lilly Recent Development
    • 10.7 Novartis
      • 10.7.1 Novartis Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Anti-inflammatory Therapeutics
      • 10.7.4 Anti-inflammatory Therapeutics Product Introduction
      • 10.7.5 Novartis Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Anti-inflammatory Therapeutics Sales Channels
      • 11.2.2 Anti-inflammatory Therapeutics Distributors
    • 11.3 Anti-inflammatory Therapeutics Customers

    12 Market Forecast

    • 12.1 Global Anti-inflammatory Therapeutics Sales and Revenue Forecast 2019-2025
    • 12.2 Global Anti-inflammatory Therapeutics Sales Forecast by Type
    • 12.3 Global Anti-inflammatory Therapeutics Sales Forecast by Application
    • 12.4 Anti-inflammatory Therapeutics Forecast by Regions
      • 12.4.1 Global Anti-inflammatory Therapeutics Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Anti-inflammatory Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Anti-inflammatoryTherapeutics. Industry analysis & Market Report on Anti-inflammatoryTherapeutics is a syndicated market report, published as Global (United States, European Union and China) Anti-inflammatory Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Anti-inflammatoryTherapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,535.44
      3,803.16
      5,070.88
      3,053.68
      4,580.52
      6,107.36
      500,823.20
      751,234.80
      1,001,646.40
      276,832.00
      415,248.00
      553,664.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report